Stay updated on PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page.

Latest updates to the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No substantive content changes to the study details or page functionality are indicated.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; this is a minor version update with no impact on study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page footer; no changes to study information or page functionality.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a glossary toggle and updated page metadata to v3.4.0 (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with capitalization adjustments. Older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4) were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with Florida as a site, replacing the old Florida Locations label; removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.2%

Stay in the know with updates to PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page.